Ποια είναι η τιμή για Lipidor AB (publ) (LIPI)

Η τιμή για Lipidor AB (publ) (LIPI) είναι $0.02243487

Ποια είναι η κεφαλαιοποίηση αγοράς για Lipidor AB (publ) (LIPI)

Η κεφαλαιοποίηση αγοράς για Lipidor AB (publ) (LIPI) είναι $650.09K

Lipidor AB (publ) (LIPI) Μετοχές σε Κυκλοφορία

Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.

Έτος	Κυκλοφορούντες μετοχές	Αλλαγή
2026 (TTM)	251.84M	-41.77%
2024	432.53M	1,392.66%
2023	28.98M	0.00%
2022	28.98M	1.83%
2021	28.45M	15.77%
2020	24.58M	21.63%
2019	20.21M	11.87%
2018	18.06M	0.00%
2017	18.06M	0.00%
2016	18.06M	0.00%

Έτος

Κυκλοφορούντες μετοχές

Αλλαγή

2026 (TTM)

251.84M

-41.77%

2024

432.53M

1,392.66%

2023

28.98M

0.00%

2022

28.98M

1.83%

2021

28.45M

15.77%

2020

24.58M

21.63%

2019

20.21M

11.87%

2018

18.06M

0.00%

2017

18.06M

0.00%

2016

18.06M

0.00%

Εταιρεία	Κυκλοφορούντες μετοχές	Διαφορά	Χώρα
Eli Lilly and Company LLY.US	892.40M	254.35%	US
Johnson & Johnson JNJ.US	2.44B	868.92%	US
AbbVie Inc. ABBV.US	1.77B	603.22%	US
Roche Holding AG RO.SW	796.00M	216.07%	CH
Merck & Co., Inc. MRK.US	0.00	-100.00%	US

Εταιρεία

Κυκλοφορούντες μετοχές

Διαφορά

Χώρα